LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis

Clinical trial NCT02098161 · COMPLETED

Trial details

NCT number: NCT02098161
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2014-12-18
Primary completion: 2022-05-19
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.